Search Results - "Mcpolin, Kira"

Risk factors for peripartum depression in women with multiple sclerosis by Krysko, Kristen M, Anderson, Annika, Singh, Jessica, McPolin, Kira, Rutatangwa, Alice, Rowles, William, Sadovnick, A Dessa, Houtchens, Maria K, Bove, Riley

“…Background: Peripartum depression (PPD) is underexplored in multiple sclerosis (MS). Objective: To evaluate prevalence of and risk factors for PPD in women…”
Get full text

Multiple sclerosis therapies differentially affect SARS-CoV-2 vaccine-induced antibody and T cell immunity and function by Sabatino, Jr, Joseph J, Mittl, Kristen, Rowles, William M, McPolin, Kira, Rajan, Jayant V, Laurie, Matthew T, Zamecnik, Colin R, Dandekar, Ravi, Alvarenga, Bonny D, Loudermilk, Rita P, Gerungan, Chloe, Spencer, Collin M, Sagan, Sharon A, Augusto, Danillo G, Alexander, Jessa R, DeRisi, Joseph L, Hollenbach, Jill A, Wilson, Michael R, Zamvil, Scott S, Bove, Riley

“…BACKGROUNDVaccine-elicited adaptive immunity is a prerequisite for control of SARS-CoV-2 infection. Multiple sclerosis (MS) disease-modifying therapies (DMTs)…”
Get full text

Humoral immune response following SARS-CoV-2 mRNA vaccination concomitant to anti-CD20 therapy in multiple sclerosis by Novak, Frederik, Nilsson, Anna Christine, Nielsen, Christian, Holm, Dorte K., Østergaard, Kamilla, Bystrup, Anna, Byg, Keld-Erik, Johansen, Isik S., Mittl, Kristen, Rowles, William, Mcpolin, Kira, Spencer, Collin, Sagan, Sharon, Gerungan, Chloe, Wilson, Michael R., Zamvil, Scott S., Bove, Riley, Sabatino, Joseph J., Sejbaek, Tobias

“…The immunogenicity of COVID-19 vaccine among patients receiving anti-CD20 monoclonal antibody (Ab) treatment has not been fully investigated. Detectable levels…”
Get full text

Longitudinal adaptive immune responses following sequential SARS-CoV-2 vaccinations in MS patients on anti-CD20 therapies and sphingosine-1-phosphate receptor modulators by Sabatino, Joseph J., Mittl, Kristen, Rowles, William, Zamecnik, Colin R., Loudermilk, Rita P., Gerungan, Chloe, Spencer, Collin M., Sagan, Sharon A., Alexander, Jessa, Mcpolin, Kira, Chen, PeiXi, Deshpande, Chinmay, Wyse, Kerri, Maiese, Eric M., Wilson, Michael R., Zamvil, Scott S., Bove, Riley

“…•Antibody levels were increased following third SARS-CoV-2 vaccine but were lower in anti-CD20 and S1P patients.•Prior treatment history with a S1P or…”
Get full text

Transitioning From S1P Receptor Modulators to B Cell–Depleting Therapies in Multiple Sclerosis: Clinical, Radiographic, and Laboratory Data by Rowles, William M., Hsu, Wan-Yu, McPolin, Kira, Li, Alyssa, Merrill, Steven, Guo, Chu-Yueh, Green, Ari J., Gelfand, Jeffrey Marc, Bove, Riley M.

“…Patients with multiple sclerosis (MS) transition from oral sphingosine-1-receptor (S1P) modulators to anti-CD20 therapies for several circumstances. Optimal…”
Get full text

Remote Observational Research for Multiple Sclerosis: A Natural Experiment by Bove, Riley, Poole, Shane, Cuneo, Richard, Gupta, Sasha, Sabatino, Joseph, Harms, Meagan, Cooper, Tifffany, Rowles, William, Miller, Nicolette, Gomez, Refujia, Lincoln, Robin, McPolin, Kira, Powers, Kyra, Santaniello, Adam, Renschen, Adam, Bevan, Carolyn J., Gelfand, Jeffrey M., Goodin, Douglas S., Guo, Chu-Yueh, Romeo, Andrew R., Hauser, Stephen L., Campbell Cree, Bruce Anthony

“…Prospective, deeply phenotyped research cohorts monitoring individuals with chronic neurologic conditions, such as multiple sclerosis (MS), depend on continued…”
Get full text